Glucotrack announces start of enrollment for human clinical study of continuous blood glucose monitor

Feasibility study underway for the company's novel continuous blood glucose monitor in patients with diabetes, with data expected within 6-8 weeks

GCTK Ratings Summary

GCTK Quant Ranking